Insight Molecular Diagnostics Inc.

US$2.49As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IMDXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (29.36%)
Div yield —
ROE —
Diagnostics & Research
Beta (5Y) 1.86
PE TTM —
TSR TTM (58.57%)
Mkt cap US$81.48M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.49
0.17%
16.25%
Hold 6|5|11|1|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
11.47%
3.96%
(5.75%)
(7.13%)
Revenue$M
7.606
7.791
8.072
8.162
0.89%
5.77%
8.60%
10.20%
Peers (US$81.48M)
Cap (US$)
PE
140.7M
—
90.00M
—
33.33M
—
75.84M
—
Capital
TTM
5Y
10Y
Leveragex
0.433
0.302
0.224
EBIT/Intx
2.173
0.343
0.338
Own earn%
(102.24)
(397.92)
(319.26)
Sh yield%
22.45
19.69
18.63
Owners
Insiders/Inst%
6.74
53.15
Short interest%
4.27
SBC / revenue%
2.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
23–30
$1 testx
—
Incr. ROIC%
4